$17.72
-0.7-3.80%
Last update: 1:23 PM
15 minutes delayed
Cartesian Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Cartesian Therapeutics using advanced sorting and filters.
Get Alert | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
RNAC | Cartesian Therapeutics | -$0.07 | -$1.19 | — | — | $5.25M | $1.83M | — | — | 08/15/2024 | Get Alert |
RNAC | Cartesian Therapeutics | -$4.24 | -$0.88 | -$10.50 | -1093.18% | $5.94M | $1.25M | $5.84M | 367.20% | 05/08/2024 | Get Alert |
RNAC | Cartesian Therapeutics | $0.04 | -$0.90 | -$41.70 | -4533.33% | $16.80M | $5.87M | $8.27M | 40.82% | 03/07/2024 | Get Alert |
RNAC | Cartesian Therapeutics | -$0.05 | -$1.80 | -$1.80 | 0.00% | $20.71M | $11.02M | $6.55M | -40.55% | 11/13/2023 | Get Alert |
RNAC | Cartesian Therapeutics | $0.06 | -$0.08 | -$0.07 | 12.50% | $39.27M | $11.09M | $5.25M | -52.67% | 08/17/2023 | Get Alert |
RNAC | Cartesian Therapeutics | $0.08 | -$0.09 | -$0.14 | -55.56% | $34.00M | $11.83M | $5.94M | -49.81% | 05/04/2023 | Get Alert |
RNAC | Cartesian Therapeutics | $0.03 | -$0.07 | $0.04 | 157.14% | $29.94M | $11.68M | $16.80M | 43.79% | 03/02/2023 | Get Alert |
RNAC | Cartesian Therapeutics | -$0.16 | -$0.01 | -$0.05 | -400.00% | $24.43M | $25.21M | $20.71M | -17.85% | 11/03/2022 | Get Alert |
RNAC | Cartesian Therapeutics | $0.00 | -$0.09 | $0.06 | 166.67% | $19.66M | — | $39.27M | — | 08/04/2022 | Get Alert |
RNAC | Cartesian Therapeutics | -$0.22 | -$0.11 | $0.08 | 172.73% | $11.05M | $13.12M | $34.00M | 159.14% | 05/05/2022 | Get Alert |
RNAC | Cartesian Therapeutics | -$0.14 | -$0.07 | $0.03 | 142.86% | $11.95M | $17.58M | $29.94M | 70.29% | 03/10/2022 | Get Alert |
RNAC | Cartesian Therapeutics | -$0.09 | -$0.07 | -$0.16 | -128.57% | $4.65M | $12.19M | $24.43M | 100.39% | 11/09/2021 | Get Alert |
RNAC | Cartesian Therapeutics | -$0.25 | -$0.12 | $0.00 | 100.00% | $0.00 | $6.24M | $19.66M | 215.11% | 08/12/2021 | Get Alert |
RNAC | Cartesian Therapeutics | -$0.21 | -$0.12 | -$0.22 | -83.33% | $0.00 | $7.52M | $11.05M | 46.94% | 05/13/2021 | Get Alert |
RNAC | Cartesian Therapeutics | -$0.28 | -$0.12 | -$0.14 | -16.67% | $6.65M | $6.37M | $11.95M | 87.61% | 03/11/2021 | Get Alert |
RNAC | Cartesian Therapeutics | -$0.26 | — | -$0.09 | — | $0.00 | — | $4.65M | — | 11/05/2020 | Get Alert |
RNAC | Cartesian Therapeutics | -$0.37 | -$0.01 | -$0.25 | -2400.00% | $13.00K | $18.75M | $0.00 | -100.00% | 08/06/2020 | Get Alert |
RNAC | Cartesian Therapeutics | -$0.31 | -$0.28 | -$0.21 | 25.00% | $10.00K | — | $0.00 | — | 05/07/2020 | Get Alert |
RNAC | Cartesian Therapeutics | -$0.65 | -$0.21 | -$0.28 | -33.33% | $903.00K | — | $6.65M | — | 03/12/2020 | Get Alert |
RNAC | Cartesian Therapeutics | -$0.71 | -$0.33 | -$0.26 | 21.21% | $0.00 | — | $0.00 | — | 11/08/2019 | Get Alert |
RNAC | Cartesian Therapeutics | -$0.84 | -$0.30 | -$0.37 | -23.33% | $0.00 | — | $13.00K | — | 08/08/2019 | Get Alert |
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Mar 2024 | 2024-05-08 | $-10.50 | $-0.88 | -1093.2 % |
Dec 2023 | 2024-03-07 | $-41.70 | $-0.90 | -4533.3 % |
Sep 2023 | 2023-11-13 | $-1.80 | $-1.80 | 0.00 % |
Jun 2023 | 2023-08-17 | $-0.07 | $-0.08 | 12.5 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Mar 2024 | 2024-05-08 | $5.84M | $1.25M | 367.2 % |
Dec 2023 | 2024-03-07 | $8.27M | $5.87M | 40.8 % |
Sep 2023 | 2023-11-13 | $6.55M | $11.02M | -40.6 % |
Jun 2023 | 2023-08-17 | $5.25M | $11.09M | -52.7 % |
Cartesian Therapeutics (RNAC) is scheduled to report earnings on August 15, 2024. The last reported earnings were for reported on May 8, 2024 for Q1.
The Actual EPS was $-10.50, which missed the estimate of $-0.88.
The Actual Revenue was $5.8M, which beat the estimate of $1.3M.
Browse earnings estimates, EPS, and revenue on all stocks.